Position in PRQR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$107,954
-$191,924 QoQ
Shares Held
58,040
-68.6% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 69 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRQR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. PRQR ranks #307 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in PRQR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,954 | 58,040 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $299,878 | 185,110 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $351,325 | 173,924 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $253,891 | 119,198 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $243,163 | 119,198 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $126,151 | 94,851 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $216,727 | 81,784 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $133,156 | 73,163 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,450 | 73,163 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $252,145 | 110,107 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $154,940 | 78,253 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $140,839 | 108,338 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $250,267 | 154,486 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $325,742 | 152,931 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $119,750 | 32,365 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,070 | 32,353 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,846 | 34,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,702 | 19,561 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,505,046 | 187,896 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $622,209 | 74,338 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,905 | 1,618 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $146,537 | 22,169 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $13,750 | 3,274 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $117,594 | 24,550 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||